All In MedTech

Device Trial Radar · NCT00234559

Trial of Vacuum Assisted Closure® Therapy Versus Control Therapy in Angiogenesis

A Randomized Controlled Study Comparing Vacuum Assisted Closure® Therapy to Moist Wound Therapy in Angiogenesis

Last checked: Nov 20, 2026Latest source record: Dec 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Sep 2005

Primary completion

Aug 2007

Study completion Aug 2007

Sponsor

Lead sponsor
KCI USA, IncNot on our public-company list
Sponsor type
Industry
First posted
Oct 7, 2005

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine: 1. If vacuum assisted closure (VAC®) therapy results in altered proteomic expression of angiogenic markers compared to moist wound therapy. 2. If VAC® therapy results in increased angiogenesis compared to moist wound therapy.

Conditions

  • Wounds

Interventions

  • VAC® Therapy SystemDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Altered proteomic expression evaluated by angiogenic markers using biomolecular assays of biopsy samples at Day 0, Day 3, Day 7, Day 21, and Day 28

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.